Esperanza de vida
Permanent URI for this collectionhttps://repositorio.sibdi.ucr.ac.cr/handle/123456789/16081
Browse
3 results
Search Results
Now showing 1 - 3 of 3
Item Genetic, dietary, and other lifestyle determinants of serum homocysteine levels in young adults in Costa Rica(Revista Panamericana de Salud Pública, vol17(4), 2005) Holst Schumacher, Ileana; Monge Rojas, Rafael; Cambronero Gutiérrez, Priscilla; Brenes Camacho, GilbertObjective: Elevated serum total homocysteine (tHcy) is considered an independent risk factor for cardiovascular disease. The objective of this study was to develop the first-ever information on the prevalence of hyperhomocysteinemia and its determinants in a population in Costa Rica. Methods: A cross-sectional study was conducted to determine serum levels of tHcy, vitamin B12, folate and creatinine, as well as the presence of the genotype TT for the methylentetratrahydrofolate reductase (MTHFR) enzyme. Additionally, dietary vitamin intakes and other lifestyle risk factors were assessed. A total of 399 Costa Rican adults from the central valley of the country (where the capital city, San José, is located), aged 20 to 40 years, participated in this study in the year 2000. Analyses of variance were performed for continuous variables, and the chi-square test was used for categorical data. Spearman correlation tests were calculated to determine associations between variables. Three linear regression analyses and one binary logistic model were developed in order to determine the predictors for homocysteine levels in the population studied. Results: The overall prevalence of hyperhomocysteinemia ( over 15 umol/L) in the population was 6%, 31% of the population were in the range of 10 to 15 umol/L, 29% had the genotype TT for the enzyme MTHFR, 18% presented a vitamin B12 deficiency ( less 165 pmol/L), and none of the persons had low serum folate levels (less 7,0 nmol/l). No significant associations were found between tHcy and age, smoking, consuming alcohol, or dietary vitamin intake. Conclusions: Only serum vitamin B12 levels and the genotype TT of the enzyme MTHFR were considered significant predictors of high serum tHcy levels in the Costa Rica population studied.Item Derivation, internal validation, and recalibration of a cardiovascular risk score for Latin America and the Caribbean (Globorisk-LAC): A pooled analysis of cohort studies(The Lancet Regional Health - Americas, 9, 2022) Stern, Dalia; Hambleton, Ian R.; Lotufo, Paulo Andrade; Di Cesare, Mariachiara; Hennis, Anselm; Ferreccio, Catterina; Irazola, Vilma; Perel, Pablo; Gregg, Edward W.; Aguilar Salinas, Carlos Alberto; Álvarez Vaz, Ramón; Amadio, Marselle Bevilacqua; Baccino, Cecilia; Bambs S., Claudia; Bastos, João Luiz Dornelles; Beckles, Gloria; Bernabé Ortiz, Antonio; Bernardo, Carla; Bloch, Katia Vergetti; Blümel, Juan Enrique; Boggia, José G.; Borges, Pollyana Kássia de Oliveira; Bravo, Miguel; Brenes Camacho, Gilbert; Carbajal, Horacio A.; Casas Vásquez, Paola; Castillo Rascón, María Susana; Ceballos, Blanca H.; Colpani, Verônica; Cooper, Jackie A.; Cortés, Sandra; Cortés Valencia, Adrián; de Sá Cunha, Roberto; d'Orsi, Eleonora; Dow, William H.; Espeche, Walter G.; Fuchs, Flavio Danni; Pereira Costa Fuchs, Sandra Cristina; Godoy Agostinho Gimeno, Suely; Gómez Velasco, Donaji Verónica; González Chica, David Alejandro; González Villalpando, Clicerio; González Villalpando, María Elena; Grazioli, Gonzalo; Guerra, Ricardo Oliveira; Gutierrez, Laura E.; Herkenhoff Vieira, Fernando Luiz; Horimoto, Andrea Roseli Vancan Russo; Huidobro Muñoz, Laura Andrea; Koch, Elard S.; Lajous Loaeza, Martin; Furtado de Lima e Costa, Maria Fernanda; López Ridaura, Ruy; Campos Cavalcanti Maciel, Álvaro; Maestre, Gladys Elena; Manrique Espinoza, Betty Soledad; Marques, Larissa Pruner; Melgarejo Arias, Jesus David; Mena Camaré, Luis Javier; Mill, Jose Gerardo; Moreira, Leila Beltrami; Muñoz Velandia, Oscar Mauricio; Ono, Lariane Mortean; Oppermann, Karen; Ortiz Saavedra, Pedro José; de Paiva, Karina Mary; Viana Peixoto, Sérgio William; da Costa Pereira, Alexandre; Peres, Karen G.; de Anselmo Peres, Marco Aurelio; Ramírez Palacios, Paula; Rech, Cassiano Ricardo; Rivera Paredez, Berenice; Rodríguez Guerrero, Nohora Inés; Rojas Martínez, Maria Rosalba; Rosero Bixby, Luis; Rubinstein, Adolfo; Ruiz Morales, Álvaro de Jesus; Salazar, Martin R.; Salinas Rodríguez, Aarón; Nájera Salmerón, Jorge Alberto; Sánchez, Ramón Augusto; de Souza e Silva, Nelson Albuquerque; Nogueira da Silva, Thiago Luiz; Smeeth, Liam; Spritzer, Poli Mara; Tartaglione, Fiorella; Tartaglione, Jorge; Tello Rodríguez, Tania; Velázquez Cruz, Rafael; Cohorts Consortium of Latin America and the Caribbean (CC-LAC); Carrillo Larco, Rodrigo Martín; Miranda Montero, Juan J.; Ezzati, Majid; Danaei, GoodarzBackground: Risk stratification is a cornerstone of cardiovascular disease (CVD) prevention and a main strategy proposed to achieve global goals of reducing premature CVD deaths. There are no cardiovascular risk scores based on data from Latin America and the Caribbean (LAC) and it is unknown how well risk scores based on European and North American cohorts represent true risk among LAC populations. Methods: We developed a CVD (including coronary heart disease and stroke) risk score for fatal/non-fatal events using pooled data from 9 prospective cohorts with 21,378 participants and 1,202 events. We developed laboratory based (systolic blood pressure, total cholesterol, diabetes, and smoking), and office-based (body mass index replaced total cholesterol and diabetes) models. We used Cox proportional hazards and held back a subset of participants to internally validate our models by estimating Harrell’s C-statistic and calibration slopes. Findings: The C-statistic for the laboratory-based model was 72% (70−74%), the calibration slope was 0.994 (0.934−1.055) among men and 0.852 (0.761−0.942) among women; for the office-based model the C-statistic was 71% (69−72%) and the calibration slope was 1.028 (0.980−1.076) among men and 0.811 (0.663−0.958) among women. In the pooled sample, using a 20% risk threshold, the laboratory-based model had sensitivity of 21.9% and specificity of 94.2%. Lowering the threshold to 10% increased sensitivity to 52.3% and reduced specificity to 78.7%. Interpretation: The cardiovascular risk score herein developed had adequate discrimination and calibration. The Globorisk-LAC would be more appropriate for LAC than the current global or regional risk scores. This work provides a tool to strengthen risk-based cardiovascular prevention in LAC.Item La medición de la esperanza de vida libre de limitaciones cognitivas y la esperanza de vida con limitaciones cognitivas en América Latina(Notas de Población, No.106, 2018) Redondo, Nélida; Brenes Camacho, Gilbert; Agudelo Botero, Marcela; Guidotti, Carolina; Romero, Dalia; Sandoval, Moisés H.En este artículo se analiza la información extraída de los censos y las encuestas nacionales de la ronda de 2010 de seis países de la región —Argentina, Brasil, Chile, Costa Rica, México y Uruguay— que aplicaron las preguntas del Grupo de Washington sobre Estadísticas de la Discapacidad, referidas a limitaciones cognitivas permanentes. En la primera parte, se hace un análisis comparativo de la esperanza de vida libre de limitaciones cognitivas y la esperanza de vida con limitaciones cognitivas permanentes a partir de los 60 años de edad, aplicando el método de Sullivan. En la segunda parte, se contrastan los resultados de las mediciones subjetivas con los de las mediciones basadas en la aplicación de pruebas específicas de deterioro cognitivo en dos de los países estudiados, a saber, Chile y Costa Rica. El análisis permite concluir que la autopercepción de limitaciones permanentes es comparable en los seis países, pese a las diferencias semánticas en la formulación de las preguntas. En cambio, se observa una brecha entre las mediciones subjetivas y las objetivas, lo que podría indicar la subestimación del fenómeno cuando se utilizan las primeras.